Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Haiyoung | - |
dc.contributor.author | Lee, Sang Mi | - |
dc.contributor.author | Yoon, Ra Gyoung | - |
dc.contributor.author | Lee, Hakmin | - |
dc.contributor.author | Lee, Ilkyun | - |
dc.contributor.author | Kim, Soon | - |
dc.contributor.author | Chung, Woong Youn | - |
dc.contributor.author | Lee, Jeong Won | - |
dc.date.accessioned | 2021-08-11T15:43:45Z | - |
dc.date.available | 2021-08-11T15:43:45Z | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 1790-5427 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7906 | - |
dc.description.abstract | Objective: In the current study, we examined whether selenium supplementation during iodine-131(I-131) treatment had a radio-protective effect on salivary glands. Subjects and Methods: Sixteen patients with differentiated thyroid cancer were prospectively enrolled in the study. Patients after total thyroidectomy, before I-131 treatment, were divided into two groups; 8 patients in the selenium group and 8 patients in the control group. Patients in the selenium group received 300 mu g of selenium orally for 10 days, from 3 days before to 6 days after I-131 treatment. The control group received a placebo over the same period. To assess salivary gland function, salivary gland scintigraphy was performed before and 6 months after I-131 treatment. Serum amylase and whole blood selenium levels were measured before and 2 days and 6 months after I-131 treatment. Using salivary gland scintigraphy, maximum uptake ratio (MUR), maximum secretion percentage (MSP), and ejection fraction (EF) of each salivary gland were calculated. Results: Baseline clinical characteristics, baseline amylase and selenium levels, and parameters of baseline salivary gland scintigraphy were not significantly different between selenium and control groups (P>0.05). On a blood test performed 2 days after (131) I treatment, the selenium group showed a significantly higher whole blood selenium level (P=0.008) and significantly lower serum amylase level (P=0.009) than the control group. On follow-up salivary gland scintigraphy, the control group showed significantly decreased, MUR of the bilateral parotid and left submandibular glands, MSP of the bilateral parotid and submandibular glands, and EF of the left submandibular glands (P<0.05), while the selenium group only had a significantly decrease in MSP of the right submandibular gland and EF of the left submandibular gland (P<0.05). Conclusion: Selenium supplementation during (131) I treatment was effective to reduce salivary glands damage by I-131 radiation in patients with differentiated thyroid cancer. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Hellenic Society of Nuclear Medicine | - |
dc.title | Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.scopusid | 2-s2.0-85021853710 | - |
dc.identifier.wosid | 000401079500011 | - |
dc.identifier.bibliographicCitation | Hellenic Journal of Nuclear Medicine, v.20, no.1, pp 62 - 70 | - |
dc.citation.title | Hellenic Journal of Nuclear Medicine | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 62 | - |
dc.citation.endPage | 70 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | RADIOIODINE THERAPY | - |
dc.subject.keywordPlus | RADIOACTIVE IODINE | - |
dc.subject.keywordPlus | DYSFUNCTION | - |
dc.subject.keywordPlus | SIALADENITIS | - |
dc.subject.keywordPlus | SCINTIGRAPHY | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordPlus | BLIND | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Selenium | - |
dc.subject.keywordAuthor | Thyroid cancer | - |
dc.subject.keywordAuthor | Iodine-131 | - |
dc.subject.keywordAuthor | Salivary gland | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.